[Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of BOC Securities Health Industry Hybrid Fund_Oriental Fortune Network

  • Post date April 24, 2022 — 09:59 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000756 000999 002020 002603 002728 002786 002938 300059 300181 Avary Holding (Shenzhen) Co Limited Bank Of China China Merchants Securities China Resources Sanjiu Medical & Pharmaceutical China Securities East Money Information Fortune Ng Fung Food Guangxi Liuzhou Pharmaceutical Hubei Jumpcan Pharmaceutical Shandong Xinhua Pharmaceutical Company Limited Shenzhen Silver Basis Technology Shijiazhuang Yiling Pharmaceutical Teyi Pharmaceutical Group Zhejiang Cheng Yi Pharmaceutical Zhejiang Huahai Pharmaceutical Zhejiang Jingxin Pharmaceutical Zhejiang Jolly Pharmaceutical Judge Management Strategy, Marketing Annual, Special Corporate Meeting Annual Report Patent, Copyright, Trademark Research, Development Agriculture Forestry, Timber Chemicals Health, Beauty Product Pharmaceutical Real Estate Coal Financial, Business Service Investments Prices Market, Exchange Securities Epidemic Medicine Traditional Chinese Medicine, Tcm Small, Medium Enterprise New Year Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data